Europe • Euronext Amsterdam • AMS:ABN • NL0011540547
We assign a fundamental rating of 3 out of 10 to ABN. ABN was compared to 114 industry peers in the Banks industry. ABN has a bad profitability rating. Also its financial health evaluation is rather negative. ABN is quite expensive at the moment. It does show a decent growth rate. Finally ABN also has an excellent dividend rating.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.52% | ||
| ROE | 7.8% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 22.73% | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.66 | ||
| Fwd PE | 11.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.16% |
ChartMill assigns a fundamental rating of 3 / 10 to ABN.AS.
ChartMill assigns a valuation rating of 3 / 10 to ABN AMRO BANK NV-CVA (ABN.AS). This can be considered as Overvalued.
ABN AMRO BANK NV-CVA (ABN.AS) has a profitability rating of 2 / 10.
The financial health rating of ABN AMRO BANK NV-CVA (ABN.AS) is 1 / 10.
The Earnings per Share (EPS) of ABN AMRO BANK NV-CVA (ABN.AS) is expected to decline by -3.5% in the next year.